Cellectar Biosciences, Inc.
CLRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001279704
No open-market purchases or sales by Cellectar Biosciences, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $9.08M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Cellectar Biosciences, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 26 | 21 | −5 |
| Shares | 1.90M | 1.71M | −188.1K (−9.9%) |
| Value | $3.22M | $2.43M | −$784.4K (−24.4%) |
New holders (1)
Institutions that held Cellectar Biosciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mendota Financial Group, LLC | 5 | $4 | 0.00% |
Sold out (6)
Institutions that held Cellectar Biosciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| CVI Holdings, LLC | 166,049 | $283.9K |
| Citadel Advisors LLC | 18,670 | $31.9K |
| Franklin Resources Inc | 10,364 | $17.7K |
| MinichMacGregor Wealth Management, LLC | 140 | $239 |
| Bank of America Corp | 20 | $34 |
| Transamerica Financial Advisors, Inc. | 5 | – |